新型药物递送系统。其对临床药代动力学研究影响的概述。 - Suppr

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

作者信息

Banerjee P S, Robinson J R

机构信息

School of Pharmacy, University of Wisconsin, Madison.

出版信息

Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001.

DOI:10.2165/00003088-199120010-00001

PMID:2029799

Abstract

摘要

相似文献

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001.

Overview of drug product development.

Curr Protoc Pharmacol. 2011 Dec;Chapter 7:Unit 7.3.1-29. doi: 10.1002/0471141755.ph0703s55.

Pediatric drug development: formulation considerations.

Drug Dev Ind Pharm. 2014 Oct;40(10):1283-99. doi: 10.3109/03639045.2013.850713. Epub 2014 Jan 31.

Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.

Eur J Pharm Biopharm. 2005 May;60(1):17-23. doi: 10.1016/j.ejpb.2004.11.010.

Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.

Clin Pharmacol Ther. 2005 Oct;78(4):322-9. doi: 10.1016/j.clpt.2005.06.012.

Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.

Expert Opin Drug Deliv. 2005 Jan;2(1):1-2. doi: 10.1517/17425247.2.1.1.

[Formulation strategies of intraoral dosage forms].

Acta Pharm Hung. 2012;82(3):95-103.

Before crushing a tablet or opening a capsule...

Prescrire Int. 2014 Sep;23(152):211.

Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.

J Pharm Pharmacol. 2012 Jul;64(7):997-1007. doi: 10.1111/j.2042-7158.2012.01534.x. Epub 2012 May 16.

Chitosan: a unique polysaccharide for drug delivery.

Drug Dev Ind Pharm. 1998 Nov;24(11):979-93. doi: 10.3109/03639049809089942.

引用本文的文献

Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles.

Drug Deliv. 2024 Dec;31(1):2425156. doi: 10.1080/10717544.2024.2425156. Epub 2024 Nov 8.

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.

Drug Des Devel Ther. 2015 Aug 5;9:4291-302. doi: 10.2147/DDDT.S86300. eCollection 2015.

The influence of frusemide formulation on diuretic effect and efficiency.

Br J Clin Pharmacol. 1999 Sep;48(3):361-6. doi: 10.1046/j.1365-2125.1999.00015.x.

The influence of drug input rate on the development of tolerance to frusemide.

Br J Clin Pharmacol. 1998 Nov;46(5):479-87. doi: 10.1046/j.1365-2125.1998.00802.x.

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.

Clin Pharmacokinet. 1996 Jan;30(1):28-51. doi: 10.2165/00003088-199630010-00003.

Influence of drug formulation on drug concentration-effect relationships.

Clin Pharmacokinet. 1994 Feb;26(2):135-43. doi: 10.2165/00003088-199426020-00006.

An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.

J Psychiatry Neurosci. 1995 Jul;20(4):287-96.

本文引用的文献

Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Pharm Res. 1984 Mar;1(2):82-8. doi: 10.1023/A:1016355431740.

Per cent absorbed time plots derived from blood level and/or urinary excretion data.

J Pharm Sci. 1963 Jun;52:610-1. doi: 10.1002/jps.2600520629.

An oral preparation to release drugs in the human colon.

Br J Clin Pharmacol. 1982 Sep;14(3):405-8. doi: 10.1111/j.1365-2125.1982.tb01999.x.

Rate-controlled drug delivery.

N Engl J Med. 1982 Jul 29;307(5):286-90. doi: 10.1056/NEJM198207293070505.

Morphine: controlled trial of different methods of administration for postoperative pain relief.

Br Med J. 1980 Jan 5;280(6206):12-3. doi: 10.1136/bmj.280.6206.12.

An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants.

J Pharmacokinet Biopharm. 1983 Aug;11(4):401-24. doi: 10.1007/BF01058958.

The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation.

Int J Clin Pharmacol Ther Toxicol. 1984 Oct;22(10):557-61.

The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.

Int J Clin Pharmacol Ther Toxicol. 1984 Aug;22(8):406-15.

Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system.

Clin Pharmacol Ther. 1984 Sep;36(3):396-401. doi: 10.1038/clpt.1984.194.

Rate-controlled delivery systems in drug and hormone research.

Annu Rev Pharmacol Toxicol. 1984;24:199-236. doi: 10.1146/annurev.pa.24.040184.001215.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献